Based on the "devaluation" of the company's market cap...How can the new CFO / COO / CEO x 2 have double the share count of long serving clinical development rep Ms. Foster? Ms. Foster arrived at the company back in 2001 / 2002 around the time our former CEO Dr. Paul Walker arrived ( April 1 2001 ) if you're paying attention to calendar dates. Ms. Foster has been "boots on the ground" so to speak as she has been highly involved in the clinical activity of the EAA, PMX and is a respected health care professional that has authored some impressive papers around both the EAA and PMX. At last count she was in the 1M+ share range all tolled and the new CFO / COO / CEO x 2 was up over the 2M share mark all tolled...It is a little hard to understand, but likely has purpose and serves as a nice Wins or Salt for "hangers-on". Given the fact insiders have a much better idea of where this is likely to go and "how it gets there" ( potentially and curiously including the # of shares the current rogue seller may have left up their slippery sleeve? ), I suppose the strategy is acceptable. I suspect when it comes to showing your shareholder base the true "marketing power" and desired "direction" of the company, it may make a lot of cents to reward anything that brings your share price to a 52 week low on the back of the firm's greatest achievements over the last 2 years!
Cheers to success and cheers to Ms. Foster for ALL her contributions and acceptance of a 50% share position and 20 years service versus 2 years of turning marvellous advances in magical black share price holes ; - ) You're a "good sport" and frankly, in what appears a "nasty game", sportsmanship is an excellent attribute - IMHO and GLTA!
Bon appetito,
Thome